These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 30518670)

  • 1. Early Caffeine Administration and Neurodevelopmental Outcomes in Preterm Infants.
    Lodha A; Entz R; Synnes A; Creighton D; Yusuf K; Lapointe A; Yang J; Shah PS;
    Pediatrics; 2019 Jan; 143(1):. PubMed ID: 30518670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of early caffeine administration and neonatal outcomes in very preterm neonates.
    Lodha A; Seshia M; McMillan DD; Barrington K; Yang J; Lee SK; Shah PS;
    JAMA Pediatr; 2015 Jan; 169(1):33-8. PubMed ID: 25402629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodevelopmental outcomes of preterm infants conceived by assisted reproductive technology.
    Roychoudhury S; Lodha A; Synnes A; Abou Mehrem A; Canning R; Banihani R; Beltempo M; Theriault K; Yang J; Shah PS; Soraisham AS; ; ;
    Am J Obstet Gynecol; 2021 Sep; 225(3):276.e1-276.e9. PubMed ID: 33798481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of inotrope use with neurodevelopmental outcomes in infants <29 weeks gestation: a retrospective cohort study.
    Doucette SM; Kelly EN; Church PT; Lee S; Shah V;
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6044-6052. PubMed ID: 33827395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity.
    Morin J; Luu TM; Superstein R; Ospina LH; Lefebvre F; Simard MN; Shah V; Shah PS; Kelly EN;
    Pediatrics; 2016 Apr; 137(4):. PubMed ID: 27244705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodevelopmental outcomes of premature infants with severe intraventricular hemorrhage.
    Calisici E; Eras Z; Oncel MY; Oguz SS; Gokce İK; Dilmen U
    J Matern Fetal Neonatal Med; 2015; 28(17):2115-20. PubMed ID: 25354288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodevelopmental Outcomes of Preterm Infants With Retinopathy of Prematurity by Treatment.
    Natarajan G; Shankaran S; Nolen TL; Sridhar A; Kennedy KA; Hintz SR; Phelps DL; DeMauro SB; Carlo WA; Gantz MG; Das A; Greenberg RG; Younge NE; Bliss JM; Seabrook R; Sánchez PJ; Wyckoff MH; Bell EF; Vohr BR; Higgins RD
    Pediatrics; 2019 Aug; 144(2):. PubMed ID: 31337693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopmental Outcomes of Infants Born at <29 Weeks of Gestation Admitted to Canadian Neonatal Intensive Care Units Based on Location of Birth.
    Amer R; Moddemann D; Seshia M; Alvaro R; Synnes A; Lee KS; Lee SK; Shah PS;
    J Pediatr; 2018 May; 196():31-37.e1. PubMed ID: 29305231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Neurodevelopmental Outcome after Doxapram for Apnea of Prematurity.
    Ten Hove CH; Vliegenthart RJ; Te Pas AB; Brouwer E; Rijken M; van Wassenaer-Leemhuis AG; van Kaam AH; Onland W
    Neonatology; 2016; 110(1):21-6. PubMed ID: 26967910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive cardiopulmonary resuscitation of preterm neonates at birth and mortality and developmental outcomes.
    Fischer N; Soraisham A; Shah PS; Synnes A; Rabi Y; Singhal N; Ting JY; Creighton D; Dewey D; Ballantyne M; Lodha A;
    Resuscitation; 2019 Feb; 135():57-65. PubMed ID: 30629993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999.
    Hintz SR; Kendrick DE; Vohr BR; Poole WK; Higgins RD;
    Pediatrics; 2005 Jun; 115(6):1645-51. PubMed ID: 15930228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Neurodevelopmental Outcomes and Neonatal Morbidities of Extremely Premature Infants With Differential Exposure to Antenatal Steroids.
    Chawla S; Natarajan G; Shankaran S; Pappas A; Stoll BJ; Carlo WA; Saha S; Das A; Laptook AR; Higgins RD;
    JAMA Pediatr; 2016 Dec; 170(12):1164-1172. PubMed ID: 27723868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Moderate and Late Preterm Birth and Neurodevelopment and Social-Emotional Development at Age 2 Years.
    Cheong JL; Doyle LW; Burnett AC; Lee KJ; Walsh JM; Potter CR; Treyvaud K; Thompson DK; Olsen JE; Anderson PJ; Spittle AJ
    JAMA Pediatr; 2017 Apr; 171(4):e164805. PubMed ID: 28152144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden.
    Serenius F; Källén K; Blennow M; Ewald U; Fellman V; Holmström G; Lindberg E; Lundqvist P; Maršál K; Norman M; Olhager E; Stigson L; Stjernqvist K; Vollmer B; Strömberg B;
    JAMA; 2013 May; 309(17):1810-20. PubMed ID: 23632725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapartum magnesium sulfate is associated with neuroprotection in growth-restricted fetuses.
    Stockley EL; Ting JY; Kingdom JC; McDonald SD; Barrett JF; Synnes AR; Monterrosa L; Shah PS; ; ;
    Am J Obstet Gynecol; 2018 Dec; 219(6):606.e1-606.e8. PubMed ID: 30240651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2007 Nov; 357(19):1893-902. PubMed ID: 17989382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
    Schmidt B; Roberts RS; Anderson PJ; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Doyle LW; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W;
    JAMA Pediatr; 2017 Jun; 171(6):564-572. PubMed ID: 28437520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Histologic Chorioamnionitis With Perinatal Brain Injury and Early Childhood Neurodevelopmental Outcomes Among Preterm Neonates.
    Bierstone D; Wagenaar N; Gano DL; Guo T; Georgio G; Groenendaal F; de Vries LS; Varghese J; Glass HC; Chung C; Terry J; Rijpert M; Grunau RE; Synnes A; Barkovich AJ; Ferriero DM; Benders M; Chau V; Miller SP
    JAMA Pediatr; 2018 Jun; 172(6):534-541. PubMed ID: 29610829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does duration of caffeine therapy in preterm infants born ≤1250 g at birth influence neurodevelopmental (ND) outcomes at 3 years of age?
    Lodha A; Rabi Y; Soraisham A; Dobry J; Lodha A; Amin H; Awad EA; Tang S; Sahai A; Bhandari V
    J Perinatol; 2018 Jul; 38(7):889-899. PubMed ID: 29740190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants.
    Taha D; Kirkby S; Nawab U; Dysart KC; Genen L; Greenspan JS; Aghai ZH
    J Matern Fetal Neonatal Med; 2014 Nov; 27(16):1698-702. PubMed ID: 24479608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.